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1055-152 Quantitative High-Resolution Magnetic Resonance 
Imaging of an Atherosclerotic Rabbit Model With a 
Whole Body 1.5Tesla Magnetic Resonance Imaging 
System
Henning Steen, Joao A. Lima, Subroto Chatterjee, Rene Rodriguez, Hugo A. Katus, 
Matthias Stuber, Johns Hopkins Hospital, Baltimore, MD, Universitätsklinik, Klinik III, 
Heidelberg, Germany
Introduction:
High Resolution MRI for atherosclerotic vessel wall characterisation and quantification is
hampered by low signal-and contrast to-noise ratio (SNR, CNR). We established an
improved microscopic 3D MRI black-blood sequence for objective vessel SNR, -CNR and
-sharpness analysis in a Watanabe model.
Methods:
Multiple subrenal ECG gated fatsat aortic 3D black blood Fast Spin Echo vessel wall
images (TR=3 RR , TE=10.5ms, TI pre/post =400/300ms, FOV=76mm, in-plane resolu-
tion=0.25mm, phase encoding= Z direction) pre and 15 min. post contrast
(Gad=0.1mmol/l) were investigated in 9 Watanabes (I=3 normals, II= 6 high cholesterol
fed for 2 months) on a 1.5T MR system (Philips Medical). SNR-, CNR-, wall thickness
and –sharpness- analysis were done semi-automatically pre-and post contrast using a
two-tailed paired Student´s t-test.
Results:
High image quality (11min/scan) could be obtained in all animals (Fig 1). In I, SNR
increased 30%, CNR 70 %. In II, SNR enhanced 297%, CNR 318%, (all p<0.05) with
insignificant increases in vessel wall thickness post contrast in I and II. Vessel sharpness
increase for I and II was similar (55% and 58%).
Discussion:
High quality aortic vessel wall images with dramatic increases of SNR and CNR post
contrast can routinely be obtained which could be invested for superior spatial resolution
to improve image quality in plaque characterization. Quantitative analysis software
proves valuable for objective assessment of atherosclerotic parameters in vessel wall dis-
ease.
1055-153 Effect of Contrast Enhancement on Measurement of 
Carotid Arterial Lumen and Wall Volume Using Magnetic 
Resonance Imaging
Binh An P. Phan, Baocheng Chu, Xue-Qiao Zhao, University of Washington, Seattle, WA
Background: Recent developments of contrast-enhanced (CE) magnetic resonance
imaging (MRI) appear to be useful in detecting neovasculature, possibly related to inflam-
mation, in carotid atherosclerotic plaques. We investigated the effect of gadolinium-
based (GAD) CE on MRI measurements of lumen and wall volumes of carotid arteries.
Methods: Common carotid arteries (CCA) and internal carotid arteries (ICA) of 50
patients were imaged on a 1.5 T MRI. 10 quadruple inversion recovery T1-weighted
images covering 20 mm of the CCA, bifurcation, and ICA were obtained before and after
GAD administration. Quantitative measurements of carotid artery lumen and wall volume
were performed using a semi-automated computer drawing program. Mean lumen and
wall volume per artery before and after GAD were compared. The mean volume change
due to CE between arteries with and without plaque involvement, and among levels of
CCA, bifurcation, and ICA were also compared.
Results: The pre-CE volume, post-CE volume, and percent volume change for the lumen
was 185.10 mm3 ± 54.46, 177.52 mm3 ± 50.21, and -3.73% ± 3.99, respectively. The pre-
CE volume, post-CE volume, and percent volume change for the wall was 84.75 mm3 ±
23.42, 108.67 mm3 ± 27.9, and 30.57% ± 20.92, respectively. The published standard
deviation (SD) on carotid measurement error using MRI is 6-10% for lumen and 11-12%
for wall measurements. There was no significant difference in volume change due to CE
in arteries with and without plaque involvement or among the levels of CCA, bifurcation,
and ICA.
Conclusion: Gadolinium-based CE-MRI images showed a significant increase in wall
volume in arteries with and without plaque involvement consistently throughout the CCA,
bifurcation, and ICA. The observed increase in wall volume is greater than twice the pub-
lished SD on wall measurement error using MRI. We hypothesize this increase in wall
volume may be due to improved wall visibility, neovascularization, or endothelium dys-
function. The post-contrast wall volume increase should be taken into consideration in
future CE-MRI studies of atherosclerotic plaque characteristics and especially in those
studies evaluating plaque progression or regression.
1055-154 Magnetic Resonance Angiography Detects In-Stent 
Thrombosis and Thrombolysis
Min Su Hyon, Hideaki Kaneda, Fumiaki Ikeno, Krishna Nayak, Alan C. Yeung, Michael V. 
McConnell, Stanford University, Stanford, CA
Background: In-stent thrombosis is rare but life-threatening. In-vivo imaging of in-stent
thrombus and its response to therapy would be beneficial. We evaluated MR angiography
(MRA) for the detection of in-stent thrombosis and for monitoring of thrombolysis in a rab-
bit model.
Methods: Minimal-artifact copper stents (3.5-4.0mm x 6-14mm) were placed at infra-
renal aorta in 16 New Zealand White rabbits. The stented aorta was imaged 1-4 days
after stenting with 1.5T MRI system using: 1) a real-time MRA (20cm FOV, 1.1 x 1.1 x
5mm, 12-30f/s), 2) a “bright-blood” coronary MRA (16cm FOV, 20 interleaves, 0.58 x 0.58
x 3mm, TR=1000 ms, TE=7ms, flip angle=60º) and 3) a T1-weighted 3D “black-blood”
SPGR with saturation slabs (TR 41ms, TE 4ms, flip angle=40°, 10cm FOV, 0.4 x 0.8 x
1.5mm). Thrombolysis using tPA (2mg/kg) was performed under monitoring with MRA.
Animals were euthanized for confirmation of thrombi.
Results: In-stent thrombosis was detected in all by MRI. Histology confirmed the
thrombi. The thrombus appeared as luminal irregularities in “bright-blood” sequence (A).
In “black-blood” sequence, thrombus appeared as a more extensive ring along the stent
as well as extending into the lumen (C). With thrombolysis, a marked decrease in in-stent
thrombosis was demonstrated with both sequences (B, D) at 1-3 hours.
Conclusions: MRA can detect in-stent thrombosis and thrombolysis using a minimal-
artifact stent. This is a promising noninvasive approach for studying arterial thrombosis
and its response to treatment.
1055-155 Antiangiogenic Therapy of Early Atherosclerosis With 
Paramagnetic αvβ3-Integrin-Targeted Fumagillin 
Nanoparticles
Patrick M. Winter, Anne M. Morawski, Shelton D. Caruthers, Thomas D. Harris, Ralph W. 
Fuhrhop, Huiying Zhang, John S. Allen, Elizabeth K. Lacy, Todd A. Williams, Samuel A. 
Wickline, Gregory M. Lanza, Washington University, St. Louis, MO
Background
αvβ3-targeted paramagnetic nanoparticles permit molecular imaging of aortic vaso
vasorum expansion in early atherosclerosis with MRI, and can simultaneously deliver tar-
geted therapeutics. In this study, αvβ3-targeted nanoparticles detected and delivered
fumagillin, a potent antiangiogenic compound, as well as assessed the extent of thera-
peutic success via MRI.
Methods
New Zealand White rabbits on a 1% cholesterol diet received αvβ3-targeted paramag-
netic nanoparticles incorporating fumagillin (Targeted, n=4) or non-targeted nanoparti-
cles (n=4). Black-blood MRI (1.5 T) of the abdominal aorta was performed before and
four hours post nanoparticle injection. MRI was repeated one week post-treatement to
assess angiogenesis in the vaso vasorum.
Results
At treatment, MRI enhancement was significantly higher with αvβ3-targeted than non-tar-
geted nanoparticles (Figure, † p < 0.05). One week after treatment, MRI enhancement
was significantly lower in αvβ3-targeted rabbits compared to non-targeted (Figure, * p <
0.05).
Conclusions
αvβ3-targeted nanoparticles sensitively detected angiogenesis within the vaso vasorum
of atherosclerosic rabbits. Simultaneous targeted delivery of fumagillin significantly
decreased the extent of neovasculture. These results suggest that MR molecular imaging
with targeted perfluorocarbon nanoparticles provides a unique tool to detect early dis-
ease, to locally deliver effective treatment, and to assess therapeutic response. 
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1055-156 Assessment of Renal Artery Stenosis by 3-D Contrast-
Enhanced and 3-D Phase-Contrast Magnetic Resonance 
Angiography: A Comparison With Conventional X-Ray 
Angiography
Juan Carlos Rozo, Scott Flamm, Brenda Lambert, Vei-Vei Lee, Eduardo Hernandez, St. 
Luke's Episcopal Hospital/Texas Heart Institute, Houston, TX
Background: The purpose of this study was to evaluate the sensitivity and specificity of
magnetic resonance angiography (MRA) using the combination of 3-D contrast-
enhanced and 3-D phase-contrast imaging as a non-invasive diagnostic modality in
patients with suspected renovascular hypertension when compared with conventional x-
ray angiography.
Methods: 134 patients underwent renal MRA prior to conventional x-ray angiography
were evaluated. Most patients were referred for MRA for further evaluation of renal insuf-
ficiency or difficult to control hypertension. MRAs were blindly evaluated independently
by a single radiologist, and renal arteriograms were evaluated by a single interventional
cardiologist.
Results: After exclusion of 19 renal arteries (7% of total renal arteries) due to prior stent-
ing or lack of selective cannulation during angiography, a total of 249 main renal arteries
were available for comparison. Polar arteries and branches were excluded from the anal-
ysis. The sensitivity and specificity for significant main renal artery stenosis defined as
narrowing of > 50 % was 90% and 91%, respectively. The positive and negative predic-
tive values were 86 % and 94 %, respectively. The Pearson correlation coefficient was
0.84 (Prob > [r] under HO: RHO=0) for MRA when compared to conventional angiogra-
phy.
Conclusion: Magnetic resonance angiography using the combination of 3-D contrast-
enhanced and 3-D phase-contrast imaging is an excellent diagnostic tool in the assess-
ment of patients with suspected renal artery stenosis.
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1056-141 Is There Value in Follow-Up Stress Testing for 
Emergency Department Patients With Chest Pain and 
Normal Rest SPECT Myocardial Perfusion?
Prem Soman, Joni R. Beshanksky, Robin Ruthazer, John L. Griffith, Gary V. Heller, 
Robert C. Hendel, J.Hector Pope, Ethan J. Spiegler, James A. Feldman, Harry P. Selker, 
James E. Udelson, Tufts-New England Medical Center, Boston, MA
Background: Normal rest myocardial perfusion imaging (MPI) in the emergency depart-
ment (ED) is associated with a high negative predictive value for acute MI and ischemia,
but how often follow-up testing is useful has not been studied.
Methods: The ERASE Chest Pain trial randomized 2,475 ED patients with suspected
cardiac ischemia, no prior MI, and a non-diagnostic ECG to usual care, or care aided by
the results of rest MPI, to determine the effect of the latter strategy on ED triage. A proto-
col-directed follow-up stress test was performed within 2 weeks (median 4 days) of the
initial ED scan in 457 pts with a normal resting ED MPI in pts with no cardiac events. Of
these, 123 (26%), 292 (63%) and 42 (9%) had treadmill exercise ECG testing only, exer-
cise MPI, and pharmacological stress MPI, respectively.
Results: Stress tests were classified as definitely normal, definitely abnormal, non-spe-
cific or non-diagnostic. 43 pts (9%) demonstrated ischemia on stress testing, while 380
(80%) were classified as definitely normal. Using stepwise multivariable regression, age
and known prior coronary artery disease (CAD) were found to be the clinical variables
that predicted the presence of abnormal stress testing after normal rest MPI (p = 0.004
and 0.006, respectively). There was an interaction between age and CAD: among pts
without prior CAD, the odds of an abnormal stress test increased with age (OR=1.5 per
10 year increase, p=0.0037), while among pts with prior CAD, there was no relationship
between age and abnormal follow-up stress test (OR=0.79 per 10 year increase,
p=0.39). Gender, history of diabetes, presence of chest pain during tracer injection for
the ED scan, and presence of symptoms in the ED did not influence the prevalence of
ischemia on follow-up stress testing.
Conclusion: A small but significant percentage of ED patients with suspected cardiac
ischemia and normal resting MPI have abnormal subsequent stress testing. While nor-
mal resting MPI in such patients predicts a good short-term outcome as established in
the ERASE Chest Pain and other trials, the presence of inducible ischemia on subse-
quent stress testing may define prognosis in the longer term, and have therapeutic impli-
cations.
1056-142 Investigation of Myocardial-Gated SPECT Imaging as an 
Initial Strategy in Heart Failure: The IMAGING in Heart 
Failure Study
Prem Soman, A. Lahiri, J. Mieres, D. Calnon, D. Wolinsky, G. A. Beller, T. Sias, K. 
Burnham, L. Conway, P. McCullough, E. Daher, M. N. Walsh, J. Wight, G. V. Heller, J. E. 
Udelson, Tufts-New England Medical Center, Boston, MA
Background: Few data exist on the prevalence of differing pathophysiologies for the initial
presentation of heart failure (HF). Methods: The IMAGING in HF trial was designed to
define the role of myocardial perfusion imaging (MPI) as an early evaluation strategy for
HF. Pts were included if they were hospitalized for first presentation of HF, fulfilled the
Framingham Study HF criteria and did not have an acute MI. Stress/rest gated SPECT
Tc-99m sestamibi imaging was performed in all pts, interpreted blindly in a central lab
and scored semi-quantitatively. Catheterization was performed based on all clinical and
imaging data.
Results: 201 pts were enrolled at 14 centers, of whom 43% were women, 65% had no
previous history of coronary artery disease (CAD), and 34% had diabetes. Stress testing
was pharmacological in 87%. LV EF was > 40% in 36%, a proportion similar to that seen
in chronic HF. Perfusion data: see Table. Among the 37% of patients who underwent cor-
onary arteriography, MPI had a 91% sensitivity, 60% specificity and 89% negative predic-
tive value (NPV) for significant CAD.
Conclusions: Gated SPECT MPI with initial presentation of HF demonstrates a distribu-
tion of ejection fractions similar to that seen in chronic HF. Extensive reversible ischemia
is present in a minority of patients, with similar prevalence in pts with preserved vs
impaired EF. Normal perfusion is seen in ~ 40%, and has a high NPV for excluding CAD.
1056-143 Standard Right Ventricular Apical Pacing Associated 
With Deterioration of Left Ventricular Function
James H. O'Keefe, Jr., Randall C. Thompson, Ravindra Kahatapitiya, Phillip G. Jones, 
Brian M. Ramza, David M. Steinhaus, Mid-America Heart Institute, Kansas City, MO
Abstract
Left ventricular (LV) ejection fraction (EF) has a powerful influence on outcome and car-
diovascular disease. We used a comprehensive prospect of nuclear database to assess
determinance of substantial improvement or deterioration in LV function over time. A total
of 17,000 consecutive patients were queried to identify patients with serial gated rest and
stress single-photon emission computed tomography (SPECT) studies at least 6 months
apart. We included only patients whose LVEF rose greater than or equal to 10 points or
fell 7 points or more. Both univariable and multivariable analyses were performed to iden-
tify significant correlates of change in LVEF over time. A total of 148 patients had EF
increase greater than or equal to 10 and 50 patients had EF decrease greater than or
equal to 7. Only patients whose baseline LVEF was between 25% and 40% were
included in the analysis. LVEF on average rose from 33% to 51% in the EF increase
group and fell from 35% to 25% in the EF decrease group. The only multivariable predic-
tor of improvement in LVEF was the use of beta blocker therapy (odds ratio 0.227, confi-
dence limits 0.09-0.050, p=0.0003). The only multivariable predictor of deterioration of LV
function was presence of a pre-existing right ventricular apical pacemaker (odds ratio
=5.4, confidence limits 1.66-19.4, p=0.006).
Conclusion
The strongest correlate of chronic improvement in LVEF was use of beta blocker therapy.
In contrast, the only significant independent predictor of deteriorating LV function over
time was use of right ventricular apical pacing. These variables should be considered
when choosing therapy for patients with depressed left ventricular ejection fraction.
1056-144 Multiexpert Blinded Interpretation of Electrocardiogram-
Gated SPECT Imaging in Women: Relative Performance 
of Thallium-201 and Technetium-99m Sestamibi
Timothy M. Bateman, Frans JTh Wackers, Jennifer H. Mieres, Kelly L. Moutray, James A. 
Case, Ginger J. Hertenstein, John A. House, S James Cullom, Mid America Heart 
Institute, Kansas City, MO, Cardiovascular Imaging Technologies, Kansas City, MO
Background: Contemporary SPECT myocardial perfusion imaging emphasizes the
importance of image quality and ECG-gating. No recent analysis of comparative accu-
racy related to choice of radionuclide has been undertaken. We studied relative perfor-
Distribution of perfusion defect severity (% of pts)
Summed 
scores
Normal /none 
%
Mild abnormal 
%
Mod-severe abnormal 
%
All 
patients
Stress
Rest
Ischemia
43
54
73
14
13
15
43
33
12
EF < 40% Ischemia 74 14 12
EF > 40% Ischemia 76 24 10
